Clinical Trials Logo
  1. Home
  2. Diabetic Neuropathy Peripheral
  3. NCT03988413

Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People

Diabetic Neuropathy Peripheral Clinical Trial

Official title:
Single-center, Randomized, Double-blind, Placebo-controlled, Single Dose Ascending Trial of SYHA1402 Tablets in Healthy Subjects

Clinical Trial Summary

The trial used single-center, randomized, double-blind, placebo-controlled, single-dose study.

The trial planned to enroll sixty-two healthy volunteers. The subjects were allocated to seven dose groups, including 25 mg (4+2), 50 mg (8+2), 100 mg (8+2), 200 mg (8+2), 400 mg (8+2), 800 mg (6+2) and 1200 mg (6+2). Each dose group was allocated test drugs and placebos according to the proportion of subjects in the brackets mentioned above.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03988413
Study type Interventional
Source CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date August 5, 2019
Completion date January 14, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05558878 - Effect of Ambroxol in Diabetic Peripheral Neuropathy N/A
Completed NCT03676595 - Video Game Balance Training for Patients With Diabetic Neuropathy N/A
Completed NCT03440203 - Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes
Completed NCT03455543 - Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy N/A
Recruiting NCT03725917 - Patients With Diabetic Neuropathy Who Receive Physiotherapy Treatment Will Have a Decrease in Diabetic Foot Ulcers N/A
Enrolling by invitation NCT03907189 - Ambulation as a Factor on Oscillating Thermometry
Completed NCT03888872 - Effect of High Tone Power Therapy on Neurophysiological Measures and Function Outcome in Patients With Diabetic Neuropathy N/A
Withdrawn NCT03354806 - Peripheral Analgesia in Painful Diabetic Neuropathy N/A
Enrolling by invitation NCT05921097 - Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
Completed NCT05299918 - Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan
Suspended NCT03685253 - Nicotinamide Riboside for Diabetic Neuropathy Phase 1/Phase 2
Completed NCT05977465 - Empagliflozin in Treatment of Peripheral Diabetic Neuropathy Phase 1/Phase 2
Not yet recruiting NCT06201611 - Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. Phase 2/Phase 3
Completed NCT03847779 - Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy N/A
Recruiting NCT05642143 - Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
Terminated NCT04253860 - Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy Phase 3
Not yet recruiting NCT05461274 - Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients
Recruiting NCT04841720 - A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets Phase 1